The immunomodulatory effect of ketamine in colorectal cancer surgery: a randomized-controlled trial
- 2 February 2021
- journal article
- research article
- Published by Springer Nature in Canadian Journal of Anesthesia/Journal canadien d'anesthésie
- Vol. 68 (5) , 683-692
Abstract
Purpose Ketamine’s inhibitory action on the N-methyl-d-aspartate receptor and anti-inflammatory effects may provide beneficial immunomodulation in cancer surgery. We investigated the effect of subanesthetic-dose ketamine as an adjunct to desflurane anesthesia on natural killer (NK) cell activity and inflammation in patients undergoing colorectal cancer surgery. Methods A total of 100 patients were randomly assigned to a control or ketamine group. The ketamine group received a bolus of 0.25 mg·kg−1 ketamine five minutes before the start of surgery, followed by an infusion 0.05 mg·kg−1·hr−1 until the end of surgery; the control group received a similar amount of normal saline. We measured NK cell activity and proinflammatory cytokines (interleukin-6 [IL-6] and tumour necrosis factor-α [TNF-α]) before surgery and one, 24, and 48 hr after surgery. C-reactive protein (CRP) was measured before surgery and one, three, and five days after surgery. Carcinoembryonic antigen and cancer recurrence/metastasis were assessed two years after surgery. Results The NK cell activity was significantly decreased after surgery in both groups, but the change was not different between groups in the linear mixed model analysis (P = 0.47). Changes in IL-6, TNF-α, CRP, and carcinoembryonic antigen levels were not different between groups (P = 0.27, 0.69, 0.99, and 0.97, respectively). Cancer recurrence within 2 years after surgery was similar between groups (10% vs 8%, P = 0.62). Conclusions Intraoperative low-dose ketamine administration did not convey any favourable impacts on overall postoperative NK cell activity, inflammatory responses, and prognosis in colorectal cancer surgery patients. Trial registration www.clinicaltrial.gov (NCT03273231); registered 6 September 2017.Keywords
Funding Information
- National Research Foundation of Korea (2017R1C1B5018102)
This publication has 44 references indexed in Scilit:
- Opioid sparing effect of low dose ketamine in patients with intravenous patient-controlled analgesia using fentanyl after lumbar spinal fusion surgeryKorean Journal of Anesthesiology, 2013
- Anesthesia in patients with cancer disordersCurrent Opinion in Anaesthesiology, 2012
- Artemisinin induces doxorubicin resistance in human colon cancer cells via calcium‐dependent activation of HIF‐1α and P‐glycoprotein overexpressionBritish Journal of Pharmacology, 2009
- The excitotoxic effect of NMDA on human lymphocyte immune functionNeurochemistry International, 2007
- Follow-up strategies for patients treated for non-metastatic colorectal cancer2007
- The Effects of Postoperative Pain Management on Immune Response to SurgeryAnesthesia & Analgesia, 2003
- Natural killer (NK) cell function is a strong prognostic factor in colorectal carcinoma patients treated with the monoclonal antibody 17‐1AInternational Journal of Cancer, 2003
- Ketamine Attenuates the Interleukin-6 Response After Cardiopulmonary BypassAnesthesia & Analgesia, 1998
- Ketamine Attenuates the Interleukin-6 Response After Cardiopulmonary BypassAnesthesia & Analgesia, 1998
- The bancroft-mackerras medal of the Australian society for parasitologyInternational Journal for Parasitology, 1983